Literature DB >> 30467047

Osimertinib for Secondary T790M-Mutation-Positive Squamous Cell Carcinoma Transformation After Afatinib Failure.

Moonkyoo Kong1, Ji-Youn Sung2, Seung Hyeun Lee3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30467047     DOI: 10.1016/j.jtho.2018.07.100

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.

Authors:  Hiroki Ota; Tomohiro Ota; Eriko Narisawa; Hideyuki Chiba; Hiroshi Nakayama; Yoko Tsukumo; Atsuhiko Sakamoto; Naoko Honma
Journal:  Intern Med       Date:  2020-07-28       Impact factor: 1.271

Review 2.  T790M mutation positive squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma after low dose erlotinib: A case report and literature review.

Authors:  Yusaku Kusaba; Yuichiro Takeda; Sakurako Abe; Akinari Tsukada; Go Naka
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

3.  Transformation of adenocarcinoma to squamous cell carcinoma as a source of EGFR-TKI resistance: A case report and literature review.

Authors:  Yun-Zhu Xi; Li Xie; Xiao-Wu Tan; Sai-Li Zeng
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.